SAR 7.65
(0.26%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 1.82 Billion | 1.83 Billion | 1.71 Billion | 1.85 Billion | 1.95 Billion |
Cost of Revenue | 1.58 Billion | 1.61 Billion | 1.45 Billion | 1.6 Billion | 1.63 Billion |
Gross Profit | 243.37 Million | 221.15 Million | 257.73 Million | 254.11 Million | 326.42 Million |
Operating Expenses | 76.99 Million | 58.41 Million | 99.35 Million | 97.42 Million | 144.46 Million |
Selling, General and Administrative Expenses | 76.99 Million | 58.41 Million | 99.35 Million | 97.42 Million | 144.46 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | - | - | - | - | - |
Cost and Expenses | 1.66 Billion | 1.67 Billion | 1.55 Billion | 1.69 Billion | 1.77 Billion |
Operating Income | 166.38 Million | 162.73 Million | 158.37 Million | 156.69 Million | 181.96 Million |
Interest Expense | - | - | - | - | - |
Income Tax Expense | 15.75 Million | 11.7 Million | 7.88 Million | 13.15 Million | 10.15 Million |
Earnings before Tax | 182.04 Million | 171.18 Million | 158.33 Million | 151.19 Million | 176.09 Million |
Net Income | 166.28 Million | 150.24 Million | 150.45 Million | 138.03 Million | 165.94 Million |
Earnings Per Share Basic | 0.42 | 0.38 | 0.38 | 0.35 | 0.41 |
Earnings Per Share Diluted | 0.42 | 0.38 | 0.38 | 0.35 | 0.41 |
Weighted Average Shares Outstanding | 400 Million | 400 Million | 400 Million | 400 Million | 400 Million |
Weighted Average Shares Outstanding (Diluted) | 400 Million | 400 Million | 400 Million | 400 Million | 400 Million |
Gross Margin | 0.13 | 0.12 | 0.15 | 0.14 | 0.17 |
EBIT Margin | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 |
Profit Margin | 0.09 | 0.08 | 0.09 | 0.07 | 0.08 |
EBITDA | 212.68 Million | 206.58 Million | 203.17 Million | 198.08 Million | 220.2 Million |
Earnings Before Tax Margin | 0.09 | 0.09 | 0.09 | 0.08 | 0.09 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 476.6 Million | 477.2 Million | 460.36 Million | 1.82 Billion | 455.6 Million | 460.63 Million |
Cost of Revenue | 424.3 Million | 417.42 Million | 392.05 Million | 1.58 Billion | 393.89 Million | 402.17 Million |
Gross Profit | 52.3 Million | 59.77 Million | 68.31 Million | 237.84 Million | 61.71 Million | 58.46 Million |
Operating Expenses | 15.6 Million | 19.64 Million | 22.01 Million | 71.46 Million | 19.3 Million | 17.26 Million |
Selling, General and Administrative Expenses | 18.03 Million | 19.64 Million | 22.01 Million | - | 19.3 Million | 17.26 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -15.6 Million | - | - | - | - | 4.5 Million |
Cost and Expenses | 439.9 Million | 437.07 Million | 414.07 Million | 1.66 Billion | 413.19 Million | 419.44 Million |
Operating Income | 36.7 Million | 40.13 Million | 46.29 Million | 166.38 Million | 42.41 Million | 41.19 Million |
Interest Expense | 1.57 Million | 1.71 Million | - | - | - | 503.49 Thousand |
Income Tax Expense | 3.33 Million | 3.33 Million | 4.69 Million | 15.75 Million | 4.52 Million | 3.09 Million |
Earnings before Tax | 39.14 Million | 41.6 Million | 49.15 Million | 182.04 Million | 48.71 Million | 45.19 Million |
Net Income | 35.81 Million | 38.27 Million | 44.46 Million | 166.28 Million | 44.19 Million | 42.09 Million |
Earnings Per Share Basic | 0.09 | 0.10 | 0.11 | - | 0.11 | 0.11 |
Earnings Per Share Diluted | 0.09 | 0.10 | 0.11 | - | 0.11 | 0.11 |
Weighted Average Shares Outstanding | 400 Million | 400 Million | 400 Million | 400 Million | 400 Million | 400 Million |
Weighted Average Shares Outstanding (Diluted) | 400 Million | 400 Million | 400 Million | 400 Million | 400 Million | 400 Million |
Gross Margin | 0.11 | 0.13 | 0.15 | 0.13 | 0.14 | 0.13 |
EBIT Margin | 0.09 | 0.10 | 0.12 | - | 0.11 | 0.10 |
Profit Margin | 0.08 | 0.08 | 0.10 | 0.09 | 0.10 | 0.09 |
EBITDA | 40.71 Million | 49.4 Million | 55.1 Million | - | 51.18 Million | 45.69 Million |
Earnings Before Tax Margin | 0.08 | 0.08 | 0.10 | 0.09 | 0.09 | 0.09 |
ADANIENSOL
RVSNW
1959
QNBK
GAUZ
SSTI